Trials / Completed
CompletedNCT02217150
The STAR Prospective Clinical Series
The DFINE STAR™ Tumor Ablation Prospective Clinical Series
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (actual)
- Sponsor
- DFINE Inc. · Industry
- Sex
- All
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
Prospective clinical series to gather post tumor ablation clinical outcomes from subjects with painful spinal metastases following targeted radiofrequency ablation (t-RFA) treatment with the STAR™ Tumor Ablation System.
Conditions
Timeline
- Start date
- 2013-06-01
- Primary completion
- 2014-12-01
- Completion
- 2016-04-01
- First posted
- 2014-08-15
- Last updated
- 2017-01-20
Locations
8 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02217150. Inclusion in this directory is not an endorsement.